PRELIMINARY-REPORT OF SAFETY FOR A PHASE-II TRIAL OF BREQUINAR SODIUM (DUP 785, NSC 368390) IN REFRACTORY SOLID TUMORS

被引：0
|
作者：
DALLAIRE, BK [1 ]
VARNS, CL [1 ]
GALBRAITH, DW [1 ]
WIELGOSZ, G [1 ]
ADAMS, DB [1 ]
BRENTZEL, HJ [1 ]
LYNCH, WJ [1 ]
CARLSON, R [1 ]
SISK, R [1 ]
AZARNIA, N [1 ]
BIGELOW, R [1 ]
BARBU, M [1 ]
GYVES, JW [1 ]
GRILLOLOPEZ, AJ [1 ]
机构：
[1] DUPONT PHARMACEUT CO,WILMINGTON,DE
来源：
CLINICAL RESEARCH | 1991年 / 39卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A375 / A375
页数：1
相关论文
共 50 条
  • [1] PHASE-I CLINICAL AND PHARMACOKINETIC TRIAL OF BREQUINAR SODIUM (DUP 785 NSC 368390)
    ARTEAGA, CL
    BROWN, TD
    KUHN, JG
    SHEN, HSL
    OROURKE, TJ
    BEOUGHER, K
    BRENTZEL, HJ
    VONHOFF, DD
    WEISS, GR
    CANCER RESEARCH, 1989, 49 (16) : 4648 - 4653
  • [2] A PRELIMINARY-REPORT OF SAFETY FOR A PHASE-II TRIAL OF DUP-937 (AN ANTHRAPYRAZOLE) IN SOLID TUMORS
    DALLAIRE, B
    FRANCHER, D
    AZARNIA, N
    WIELGOSZ, G
    ADAMS, D
    LYNCH, W
    VARNS, C
    BUNITSKY, K
    VANDERTUIN, L
    GRACE, M
    CARON, M
    BARBU, M
    SISK, R
    STOLTZFUS, K
    CARLSON, R
    GRILLOLOPEZ, A
    GYVES, J
    CLINICAL RESEARCH, 1992, 40 (02): : A420 - A420
  • [3] PHASE-I STUDY OF DUP-785 (NSC 368390) IN SOLID TUMORS
    JOGGI, J
    SCHWARTSMANN, G
    HUININK, WT
    DODION, P
    WINOGRAD, B
    VERMORKEN, J
    CRESPEIGNE, N
    WERY, F
    VANDERVIJGH, W
    PINEDO, H
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 229 - 229
  • [4] PHARMACOKINETICS OF BREQUINAR SODIUM (NSC-368390 - DUP-785) IN CEREBROSPINAL-FLUID
    SCHWARTSMANN, G
    VANDERVIJGH, WJF
    KLEIN, I
    VANGROENINGEN, CJ
    VERMORKEN, JB
    PINEDO, HM
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (12): : 1903 - 1904
  • [5] PHASE-I STUDY OF DUP-785 (NSC-368390) IN SOLID TUMORS
    PINEDO, HM
    VANDENVIJGH, WJF
    VONLOCNHOUT, WJA
    SCHWARTSMANN, G
    HOCHSTER, H
    HUININK, WWT
    KLEIN, I
    DODION, P
    WINOGRAD, B
    VERMORKEN, JB
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 133 - 133
  • [6] Pharmacokinetic and phase I studies of brequinar (DUP 785; NSC 368390) in combination with cisplatin in patients with advanced malignancies
    Burris, HA
    Raymond, E
    Awada, A
    Kuhn, JG
    O'Rourke, TJ
    Brentzel, J
    Lynch, W
    King, SYP
    Brown, TD
    Von Hoff, DD
    INVESTIGATIONAL NEW DRUGS, 1998, 16 (01) : 19 - 27
  • [7] PHASE-II TRIAL WITH BREQUINAR (DUP-785, NSC-368390) IN PATIENTS WITH METASTATIC COLORECTAL-CANCER - A STUDY OF THE EARLY CLINICAL-TRIALS GROUP OF THE EORTC
    DODION, PF
    WAGENER, T
    STOTER, G
    DROZD, A
    LEV, LM
    SKOVSGAARD, T
    RENARD, J
    CAVALLI, F
    ANNALS OF ONCOLOGY, 1990, 1 (01) : 79 - 80
  • [8] A PHASE I CLINICAL AND PHARMACOKINETIC STUDY OF BREQUINAR SODIUM, DUP-785 (NSC-368390), USING A WEEKLY AND A BIWEEKLY SCHEDULE
    BORK, E
    VEST, S
    HANSEN, HH
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (10): : 1403 - 1411
  • [9] Pharmacokinetic and phase I studies of brequinar (DUP 785; NSC 368390) in combination with cisplatin in patients with advanced malignancies
    Burris III H.A.
    Raymond E.
    Awada A.
    Kuhn J.G.
    O'Rourke T.J.
    Brentzel J.
    Lynch W.
    King S.-Y.P.
    Brown T.D.
    Von Hoff D.D.
    Investigational New Drugs, 1998, 16 (1) : 19 - 27
  • [10] PHASE-I AND PHARMACOKINETIC STUDY OF BREQUINAR (DUP-785 NSC-368390) IN CANCER-PATIENTS
    DEFORNI, M
    CHABOT, GG
    ARMAND, JP
    FONTANA, X
    RECONDO, G
    DOMENGE, C
    CARDE, P
    BARBU, M
    GOUYETTE, A
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (07) : 983 - 988
12345